NCT06583798

Brief Summary

Anatomical and Visual outcomes of retinal re-surgeries done in silicone oil filled eyes

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2023

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 24, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 4, 2024

Completed
Last Updated

September 25, 2024

Status Verified

September 1, 2024

Enrollment Period

12 months

First QC Date

August 24, 2024

Last Update Submit

September 23, 2024

Conditions

Keywords

Retinal Re-detachmentIn silicone filled eyesUnder silicone oilProliferative Vitreoretinopathy

Outcome Measures

Primary Outcomes (2)

  • Change in Best Corrected Visual Acuity as assessed by LogMAR (Logarithm Minimum Angle of Resolution) chart

    * Change in mean Best Corrected Visual Acuity from Pre-operative time to 6 months post Re-surgery in silicone oil filled eyes * Change in mean Best Corrected Visual Acuity from Pre-operative time to 6 months post Re-surgery in silicone oil filled eyes with primary diagnosis of Diabetic Macular Tractional detachment * Change in mean Best Corrected Visual Acuity from Pre-operative time to 6 months post Re-surgery in silicone oil filled eyes with primary diagnosis of Rhegmatogenous retinal detachment * Change in mean Best Corrected Visual Acuity from Pre-operative time to 1month post Silicone oil Removal in eyes undergoing Silicone oil removal after Re-surgery in silicone oil filled eyes

    6 months after Resurgery; 1 month post Silicone oil removal in eyes undergoing silicone oil removal

  • Number and Percentage of eyes with Retina Reattched after resurgery in Silicone oil filled eyes

    * Total Number and Percentage of eyes with Retina Re-attached after re-surgery in Silicone oil filled eyes * Number and Percentage of eyes with Retina Re-attached after re-surgery in Silicone oil filled eyes having primary diagnosis of Diabetic Macular Tractional Detachment * Number and Percentage of eyes with Retina Re-attached after re-surgery in Silicone oil filled eyes having primary diagnosis of Rhegmatogenous retinal Detachment * Number and Percentage of eyes after re-surgery in Silicone oil filled eyes who underwent Silicone oil removal later * Number and Percentage of eyes who had retinal re-detachment after undergoing Silicone oil removal later

    •6 months post resurgery; •3 months post silicone oil removal in Patients who underwent silicone oil removal

Secondary Outcomes (4)

  • number and percentage of patients having Best Corrected Visual Acuity of 1.6 Log Units

    6 months

  • Number and percentage of eyes/patients having various risk factors for retinal detachment after primary surgery in silicone oil filled eyes

    6 months

  • Number and percentage of eyes/patients with adverse events intraoperative and post re-surgery in silicone oil filled eyes

    6 months post resurgery; 3 months post Silicone oil removal

  • IOP change post Retinal Resurgery in silicone oil filled eyes

    6 months

Interventions

* Alcon Luxor Biomicroscope with Non-contact BIOM (binocular indirect ophthalmomicroscope) viewing system was used. * 2 ports were made in Pars plana. * Top up of Silicone oil was done whenever needed. * Membrane peeling with relaxing retinectomy / drainage retinotomy, haemostasis and endolaser were done under Silicone oil as required. * After the re surgery, the patients were advised to maintain prone position.

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients (South Indian Population) who attended retina Out patient department in Ahalia Foundation Eye Hospital, Palakkad and had to undergo Resurgery for Retinal Redetachment in various retinal pathologies

You may qualify if:

  • Patients who had under gone the primary retina surgery at Ahalia Foundation Eye Hospital / elsewhere for retinal detachment secondary to various retinal pathologies and underwent re surgery during their follow up at Ahalia Foundation Eye Hospital during the study period.
  • Patients whose proper follow up to 6 months after re surgery were maintained during the study period.
  • No history of any additional eye disease other than h/o cataract surgery or primary RD repair.
  • Patients who were willing to be a part of the study and willing to provide informed written consent.

You may not qualify if:

  • Patients who did not come for any of the follow up included in the study.
  • Patients who had history of ocular trauma after the primary surgery.
  • Patients who have any other ocular comorbidities other than cataract.
  • Patients who had undergone multiple previous re surgeries for retinal detachment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ahaliafoundation Eye Hospital

Palakkad, Kerala, 678557, India

Location

MeSH Terms

Conditions

Retinal DetachmentVitreoretinopathy, Proliferative

Condition Hierarchy (Ancestors)

Retinal DiseasesEye Diseases

Study Officials

  • Rajkumar Maheshwari, MS

    Ahalia Foundation Eye Hospital

    PRINCIPAL INVESTIGATOR
  • C R Asla Jahan, DNB

    Ahalia Foundation Eye Hospital

    PRINCIPAL INVESTIGATOR
  • Saurav Mahajan, MS

    Ahalia Foundation Eye Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Clinical Professor Adjunct

Study Record Dates

First Submitted

August 24, 2024

First Posted

September 4, 2024

Study Start

January 1, 2023

Primary Completion

December 31, 2023

Study Completion

June 30, 2024

Last Updated

September 25, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations